Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk
Gregory Idos(City Of Hope National Medical Center), Stephen B. Gruber(City Of Hope National Medical Center), Meredith Mills(Cargill (Netherlands)), Alexandra Lebensohn(National Institutes of Health), Courtney Rowe‐Teeter(Stanford University), Kerry Kingham(Cargill (Netherlands)), Richard Wenstrup, Johnathan M. Lancaster(University of South Florida), Katrina Lowstuter(University of Southern California), Katlyn Partynski(University of Southern California), S. Cindy(Garvan Institute of Medical Research), Brian Allen(Myriad Genetics), Charité Ricker(Keck Hospital of USC), Brent Evans(AstraZeneca (United States)), John Kidd(Myriad Genetics), Allison W. Kurian(Stanford University), Julie O. Culver(City of Hope), Rachel Koff(Stanford University), Anne‐Renee Hartman, Christine Hong(City Of Hope National Medical Center), Peter Levonian(Stanford University), Bhramar Mukherjee(Michigan Medicine), Iva Petrovchich(Stanford University), Uri Ladabaum(Stanford University), Nicolette M. Chun(Stanford University), Kevin McDonnell(City Of Hope National Medical Center), James M. Ford(Palo Alto University), Krystal Brown(Myriad Genetics), Duveen Sturgeon(City Of Hope National Medical Center)
Cited by 52
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862